80 related articles for article (PubMed ID: 15858841)
1. PEGylation of yeast cytosine deaminase for pretargeting.
Xiong MP; Kwon GS
J Pharm Sci; 2005 Jun; 94(6):1249-58. PubMed ID: 15858841
[TBL] [Abstract][Full Text] [Related]
2. Transduction of yeast cytosine deaminase mediated by HIV-1 Tat basic domain into tumor cells induces chemosensitivity to 5-fluorocytosine.
Lee H; Ryu J; Kim KA; Lee KS; Lee JY; Park JB; Park J; Choi SY
Exp Mol Med; 2004 Feb; 36(1):43-51. PubMed ID: 15031670
[TBL] [Abstract][Full Text] [Related]
3. Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
Yao L; Li Y; Wu Y; Liu A; Yan H
Biochemistry; 2005 Apr; 44(15):5940-7. PubMed ID: 15823054
[TBL] [Abstract][Full Text] [Related]
4. Role of glutamate 64 in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
Wang J; Sklenak S; Liu A; Felczak K; Wu Y; Li Y; Yan H
Biochemistry; 2012 Jan; 51(1):475-86. PubMed ID: 22208667
[TBL] [Abstract][Full Text] [Related]
5. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.
Kievit E; Bershad E; Ng E; Sethna P; Dev I; Lawrence TS; Rehemtulla A
Cancer Res; 1999 Apr; 59(7):1417-21. PubMed ID: 10197605
[TBL] [Abstract][Full Text] [Related]
6. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
[TBL] [Abstract][Full Text] [Related]
7. Oncosuppressive suicide gene virotherapy "PVH1-yCD/5-FC" for pancreatic peritoneal carcinomatosis treatment: NFκB and Akt/PI3K involvement.
Réjiba S; Bigand C; Parmentier C; Masmoudi A; Hajri A
PLoS One; 2013; 8(8):e70594. PubMed ID: 23967078
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
9. Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine.
Li JJ; Chang SF; Liau II; Chan PC; Liu RS; Yen SH; Wang HE; Chang CA
J Biomed Sci; 2016 Jan; 23():15. PubMed ID: 26801910
[TBL] [Abstract][Full Text] [Related]
10. Exploring Product Release from Yeast Cytosine Deaminase with Metadynamics.
Croney KA; McCarty J
J Phys Chem B; 2024 Apr; 128(13):3102-3112. PubMed ID: 38516924
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene.
Fuerer C; Iggo R
Gene Ther; 2004 Jan; 11(2):142-51. PubMed ID: 14712298
[TBL] [Abstract][Full Text] [Related]
12. Combined QM(DFT)/MM molecular dynamics simulations of the deamination of cytosine by yeast cytosine deaminase (yCD).
Zhang X; Zhao Y; Yan H; Cao Z; Mo Y
J Comput Chem; 2016 May; 37(13):1163-74. PubMed ID: 26813441
[TBL] [Abstract][Full Text] [Related]
13. Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
Zamboni S; Mallano A; Flego M; Ascione A; Dupuis ML; Gellini M; Barca S; Cianfriglia M
Int J Oncol; 2008 Jun; 32(6):1245-51. PubMed ID: 18497986
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of a novel chitosan based E. coli cytosine deaminase nanocomposite for potential application in prodrug enzyme therapy.
Yata VK; Ghosh SS
Biotechnol Lett; 2011 Jan; 33(1):153-7. PubMed ID: 20960222
[TBL] [Abstract][Full Text] [Related]
15. Catalytic mechanism of yeast cytosine deaminase: an ONIOM computational study.
Sklenak S; Yao L; Cukier RI; Yan H
J Am Chem Soc; 2004 Nov; 126(45):14879-89. PubMed ID: 15535715
[TBL] [Abstract][Full Text] [Related]
16. Product release mechanism and the complete enzyme catalysis cycle in yeast cytosine deaminase (yCD): A computational study.
Zhao Y; She N; Zhang X; Wang C; Mo Y
Biochim Biophys Acta Proteins Proteom; 2017 Aug; 1865(8):1020-1029. PubMed ID: 28478051
[TBL] [Abstract][Full Text] [Related]
17. [Study on the in vivo killing activity of YCD/5-FC gene therapy system on K562B cells].
Zhang Y; Wang J; Zhou H; Zhai Y
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):173-5. PubMed ID: 12133450
[TBL] [Abstract][Full Text] [Related]
18. Multimodal image-guided enzyme/prodrug cancer therapy.
Li C; Winnard PT; Takagi T; Artemov D; Bhujwalla ZM
J Am Chem Soc; 2006 Nov; 128(47):15072-3. PubMed ID: 17117842
[TBL] [Abstract][Full Text] [Related]
19. A molecular dynamics exploration of the catalytic mechanism of yeast cytosine deaminase.
Yao L; Sklenak S; Yan H; Cukier RI
J Phys Chem B; 2005 Apr; 109(15):7500-10. PubMed ID: 16851861
[TBL] [Abstract][Full Text] [Related]
20. Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.
Kucerova L; Matuskova M; Hlubinova K; Bohovic R; Feketeova L; Janega P; Babal P; Poturnajova M
Cancer Lett; 2011 Dec; 311(1):101-12. PubMed ID: 21824724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
